PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4350
-0.0150 (-3.33%)
At close: Mar 3, 2026
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 72.61 million as of March 4, 2026. Its market cap has increased by 8.61% in one year.
Market Cap
72.61M
Enterprise Value
72.14M
Revenue
17.60M
Ranking
n/a
PE Ratio
269.35
Stock Price
0.44
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 72.61M, an increase of 2,925.55%. That is a compound annual growth rate of 170.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 72.61M | -4.40% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Extendicare | 2.50B |
| Curaleaf Holdings | 2.35B |
| Sienna Senior Living | 2.33B |
| Green Thumb Industries | 2.02B |
| BioNxt Solutions | 78.96M |
| Theralase Technologies | 76.85M |
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 73.41M |